20
Jul
Appointment of Fred S. Zeidman to the Board of Directors of Bluejay Diagnostics, Inc.
Bluejay Diagnostics, Inc. (the “Company”), announced today that Mr. Fred S. Zeidman has been appointed to the Boards of Directors and Chairman of Nominating and Corporate Governance Committee of the Company. The Board of Directors ratified and approved, the appointment of Mr. Zeidman to the Board of Directors. The appointment of Mr. Zeidman to the
read more
14
Dec
Bluejay Diagnostics, Inc. Announces Collaboration Agreement with Toray Industries, Inc. To Develop Point of Care Test for Covid-19 Patient Triage
Collaboration focused on developing point of care diagnostic test to quantify IL-6 in whole blood. Acton, MA, Dec 8, 2020 – Bluejay Diagnostics, Inc. (Bluejay, Acton, MA) today announced a collaboration agreement with Toray Industries, Inc. (Toray, Tokyo, Japan) to develop a minimally-invasive, point-of-care test for COVID-19 patients to assess progression of the disease. Symphony™
read more
22
May
Bluejay Diagnostics’ Board of Directors Announces Appointment of Douglas C. Wurth as Chairman
Acton, MA – May 22, 2017 – Bluejay Diagnostics, Inc. (Bluejay) today announced that its board of directors unanimously named Douglas C. Wurth as the Company’s chairman, effective immediately. Mr. Wurth recently retired from J.P. Morgan Chase after a successful 19-year career with the Firm, where he was the Chief Executive Officer of Alternative Investments
read more